Merck Announces First-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Merck (MRK) Tops Q1 EPS by 31c; Raises Outlook
April 28, 2022 6:32 AM EDTMerck (NYSE: MRK) reported Q1 EPS of $2.14, $0.31 better than the analyst estimate of $1.83. Revenue for the quarter came in at $15.9 billion versus the consensus estimate of $14.71 billion.
GUIDANCE:
Merck sees FY2022 EPS of $7.24-$7.36, versus the consensus of $7.24. Merck sees... More
